fingolimod 0.25 MG Disintegrating Oral Tablet
RxNorm concept 2610295, clinical drug (scd).
- RxCUI
- 2610295
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2610295 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
fingolimod 0.25 MG (as fingolimod lauryl sulfate 0.47 MG) Disintegrating Oral Tablet
Related concepts
- fingolimod 0.25 MG (SCDC, consists of)
- Disintegrating Oral Tablet (DF, has dose form)
- fingolimod 0.25 MG Disintegrating Oral Tablet [Tascenso] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2610295 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2610295 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2610295. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.